Financhill
Sell
27

MLTX Quote, Financials, Valuation and Earnings

Last price:
$39.59
Seasonality move :
-6.98%
Day range:
$37.70 - $39.98
52-week range:
$36.52 - $58.26
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.48x
Volume:
568.7K
Avg. volume:
332.5K
1-year change:
-18.16%
Market cap:
$2.4B
Revenue:
--
EPS (TTM):
-$1.89

Earnings Data

Next earnings date for MLTX
May 07
2025
Most recent earnings per share
-$0.72
Missed by $0.13
(Feb 26/2025)
Consensus Estimate
-$0.59
(Feb 26/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MLTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/07/2025 Q1 -- -- -- -$0.76 --
02/26/2025 Q4 -- -- -$0.72 -$0.59 -$0.13
11/07/2024 Q3 -- -- -$0.56 -$0.45 -$0.11
08/07/2024 Q2 -- -- -$0.39 -$0.28 -$0.11
05/07/2024 Q1 -- -- -$0.22 -$0.21 -$0.01
02/29/2024 Q4 -- -- -$0.10 -$0.27 $0.17
11/14/2023 Q3 -- -- -$0.18 -$0.25 $0.07
08/10/2023 Q2 -- -- -$0.23 -$0.29 $0.06
05/11/2023 Q1 -- -- -$0.23 -$0.29 $0.06
03/20/2023 Q4 -- -- -$0.31 -$0.28 -$0.03
11/14/2022 Q3 -- -- -$0.27 -- --
08/12/2022 Q2 -- -- -$0.34 -- --
03/31/2022 Q1 -- -- -$0.43 -- --
09/30/2021 Q3 -- -- -$0.17 -- --
06/30/2021 Q2 -- -- -$0.89 -- --

MoonLake Immunotherapeutics Earnings Questions

  • How Much did MoonLake Immunotherapeutics Generate in Revenue Last Quarter?

    MoonLake Immunotherapeutics reported -- worth of top line sales in its most recent quarter.

  • Did MoonLake Immunotherapeutics Beat Earnings Last Quarter?

    MoonLake Immunotherapeutics announced earnings per share of -$0.72 which represents a miss of analyst forecast a -$0.59 per share.

  • Is MoonLake Immunotherapeutics Profitable?

    MoonLake Immunotherapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for MoonLake Immunotherapeutics EPS Next Year?

    MoonLake Immunotherapeutics's earnings are forecast to decrease from -$1.89 per share to -$1.72 per share next year representing a decrease of -66.19%.

  • When is MoonLake Immunotherapeutics's Earnings Date?

    MoonLake Immunotherapeutics's next earnings date is May 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock